By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IOMAI Corporation 

20 Firstfield Road, Suite 250

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-556-4500 Fax: 301-556-4501


Company News
Intercell AG Buys IOMAI Corporation (IOMI) for $189 Million 8/6/2008 7:36:24 AM
IOMAI Corporation (IOMI) Stockholders Approve Merger With Intercell AG Subsidiary 8/1/2008 7:37:58 AM
IOMAI Corporation (IOMI) Likely to Sell to Intercell AG Sooner than Expected 7/14/2008 7:41:53 AM
IOMAI Corporation (IOMI) Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6/12/2008 9:03:57 AM
IOMAI Corporation (IOMI) to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT 5/14/2008 8:13:20 AM
Intercell AG to Acquire IOMAI Corporation (IOMI) to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation for About $189M 5/13/2008 7:09:41 AM
IOMAI Corporation (IOMI) Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4/16/2008 7:42:40 AM
IOMAI Corporation (IOMI) Receives Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4/15/2008 8:40:06 AM
IOMAI Corporation (IOMI) Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 4/8/2008 10:07:44 AM
IOMAI Corporation (IOMI) and Merck & Co., Inc. (MRK) Evaluate Use of Iomai Immunostimulant Patch 4/3/2008 7:53:02 AM